News

Filter

Current filters:

None

28 to 37 of 97840 results

Ipsen pays 6 million euros for option to acquire Canbex

24-02-2015

French drugmaker Ipsen today announced that UK-based biotech firm Canbex Therapeutics has granted an…

BiotechnologyCanbex TherapeuticsIpsenMergers & AcquisitionsNeurologicalVSN16R

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Ferring acquires novel drug delivery technology from CTCBIO

24-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has signed an agreement with CTCBIO…

CTCBIOFerring PharmaceuticalsLicensingPharmaceutical

Aquavit to invest in biopharma R&D and manufacturing in South Korea

24-02-2015

Aquavit Life Sciences, the South Korea-based subsidiary of privately-held US firm Aquavit Pharmaceuticals,…

AquavitPharmaceuticalProductionResearchSouth Korea

Health care is up for a revolution with the rise of personal genomic tests; report

24-02-2015

As the era of personalized medicine dawns on health care, the need to understand an individual’s genetic…

BiotechnologyGlobalRegulationResearch

TWi Pharmaceuticals to use its own subsidiary in USA instead of Teva

24-02-2015

Generic drugmakers Taiwan-based TWi Pharmaceuticals and Israeli company Teva Pharmaceutical Industries…

GenericsLicensingLidodermMegace ESOncologyTeva Pharmaceutcal IndustriesTWi PharmaceuticalsUSA

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

24-02-2015

The Medicines Patent Pool has announced a license with US pharma giant Merck & Co for pediatric formulations…

Anti-viralsMerck & CoPharmaceuticalProductionRaltegravir Tablets

US FDA approves Novartis’ Farydak, the first HDAC inhibitor for MM patients

24-02-2015

The US Food and Drug Administration yesterday approved Swiss pharma giant Novartis’ Farydak (panobinostat,…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

Eli Lilly delays US and Europe filings for new diabetes agent peglispro

23-02-2015

US pharma major Eli Lilly says it is delaying the submission of its basal insulin peglispro (BIL) to…

DiabetesEli LillyEuropepeglisproPharmaceuticalRegulationUSA

28 to 37 of 97840 results

COMPANY SPOTLIGHT

Menarini

Back to top